药物对比
Acarbose vs Repaglinide
比较Acarbose（Precose）与Repaglinide治疗2型糖尿病：作用机制、疗效、胃肠道 vs 低血糖风险，以及哪种口服药物可能更适合餐后血糖控制需求。
此页面暂无可用的对比维度。
临床背景
Type 2 diabetes patients needing an oral agent focused on postprandial glucose spikes often compare an alpha-glucosidase inhibitor versus a meglitinide.
结论
Acarbose is generally safer regarding hypoglycemia while Repaglinide typically provides more potent glycemic control, so selection hinges on individual risk factors.
全部药物对比